Venmax Drugs And Pharmaceuticals Ltd.

Name: Venmax Drugs And Pharmaceuticals Ltd. Share Price Today, Stock Analysis
Brand: Venmax Drugs And Pharmaceuticals Ltd.

Stock Card

BSE: 531015

₹14.50

₹-0.31 (-2.09%)

As on 01-Oct-2026IST

Market cap

₹21 Cr

Revenue (TTM)

₹9 Cr

P/E Ratio

74.7

P/B Ratio

Div. Yield

0 %

Venmax Drugs Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 14.11 High: 15.00

52 Week Range

Low: 12.71 High: 31.49

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹0 Cr
ROE

0 %
ROCE

-0.6 %
Industry P/E

45.27
EV/EBITDA

64.7
Debt to Equity

-0.1
Book Value

₹14.4
EPS

₹0.3
Face value

10
Shares outstanding

14,483,929

10 Years Aggregate

CFO

₹-1.95 Cr

EBITDA

₹-3.29 Cr

Net Profit

₹-0.26 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Venmax Drugs	-41.9	-7.7	-17.3	-31.4	--	--	19.5
BSE Healthcare	14.9	-3.2	1.2	15.8	20.5	13.8	11.9

As on 01-Oct-2026

Company	2025
Venmax Drugs	31.7
BSE Small Cap	-6.6
BSE Healthcare	-3.3

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Venmax Drugs	14.5	21.0	9.3	0.3	1.6	2.3	74.7	1.0
Acutaas Chemicals	3,196.5	26,159.9	1,461.8	387.4	34.5	25.2	67.7	15.2
Alembic Pharma	815.3	16,019.9	7,784.0	688.5	10.6	14	23.1	2.7
Cohance Lifesciences	451.3	17,272.4	2,141.5	58.5	5.8	3.3	162.6	4.5
Granules India	821.8	22,389.8	5,632.3	662.4	17.2	14.3	33.8	4.6
Jubilant Pharmova	999.3	15,938.5	8,608.3	351.6	8.7	5.7	45.3	2.2
Onesource Specialty Pharma	1,508.0	17,312.9	1,543.3	-48.6	3.6	-0.6	--	3.0
Piramal Pharma	198.0	26,327.4	9,205.3	-371.8	1.7	-3.8	--	3.3
Rubicon Research	1,630.9	27,051.2	1,935.8	288.2	20.6	29.8	93.9	20.2
Wockhardt	2,083.9	33,904.0	3,564.0	414.0	15.3	8.4	82.9	6.7

Shareholding Pattern

View Details

News & Analysis

All News

No Review & Analysis are available.

About Venmax Drugs

Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable... alkaloids; Read more

Incorporated

1988
Chairman

--
Managing Director

--
Headquarters

Hyderabad, Telangana
Website

www.venmaxdrugs.com

FAQs for Venmax Drugs

What is the current share price of Venmax Drugs And Pharmaceuticals Ltd Today?

The share price of Venmax Drugs And Pharmaceuticals Ltd is ₹14.50 (BSE) as of 01-Oct-2026 IST. Venmax Drugs And Pharmaceuticals Ltd has given a return of -31.44% in the last 1 years.

What is the current PB & PE ratio of Venmax Drugs And Pharmaceuticals Ltd?

The P/E ratio of Venmax Drugs And Pharmaceuticals Ltd is 74.74 times as on 01-Oct-2026, a 65 premium to its peers’ median range of 45.27 times.
The P/B ratio of Venmax Drugs And Pharmaceuticals Ltd is 1.01 times as on 01-Oct-2026, a 78 discount to its peers’ median range of 4.57 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	0.00	-22.62
2024	0.00	0.00
2023	0.00	0.00
2022	0.00	0.00
2021	0.00	0.00

What is the 52 Week High and Low of Venmax Drugs And Pharmaceuticals Ltd?

The 52-week high and low of Venmax Drugs And Pharmaceuticals Ltd are Rs 31.49 and Rs 12.71 as of 02-Oct-2026.

What is the market cap of Venmax Drugs And Pharmaceuticals Ltd?

Venmax Drugs And Pharmaceuticals Ltd has a market capitalisation of ₹ 21 Cr as on 01-Oct-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Venmax Drugs And Pharmaceuticals Ltd?

Before investing in Venmax Drugs And Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.